Skip to main content
Log in

Newborn screening for congenital CMV cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2016 US dollars

References

  1. Gantt S, et al. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection. JAMA Pediatrics : 10 Oct 2016. Available from: URL: http://doi.org/10.1001/jamapediatrics.2016.2016.

  2. Demmler-Harrison GJ. Congenital Cytomegalovirus Infection: The Elephant in Our Living Room. JAMA Pediatrics : 10 Oct 2016. Available from: URL: http://dx.doi.org/10.1001/jamapediatrics.2016.2892.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Newborn screening for congenital CMV cost effective. PharmacoEcon Outcomes News 764, 27 (2016). https://doi.org/10.1007/s40274-016-3476-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3476-4

Navigation